APR 02, 2021 6:44 AM PDT

Missing link identified for "bad" cholesterol

New research from a team at the University of Alberta has identified the protein that is associated with low-density lipoprotein cholesterol, or the “bad” cholesterol that can cause atherosclerosis. This information has been highly sought after for years because it provides an opportunity to target the protein in drug development. The findings are published in the journal Nature Communications.

Photo: Pixabay

"We have known for many years that these receptors could be cleaved, but nobody knew which protein was responsible," commented Dawei Zhang, associate professor of pediatrics in the Faculty of Medicine & Dentistry. "There had been several attempts around the world but nobody else was successful."

Zhang’s research team has already begun an investigation to develop a drug that targets the protein, called membrane type 1 matrix metalloproteinase, which would allow LDL receptors to clear the bad cholesterol from the blood. Needless to say, such a drug would have serious implications for patients with high cholesterol and at risk of heart attack or stroke. Zhang says that the new drug would likely work in combination with the common class of drugs known as statins, which are used to reduce cardiac events. 

In addition to playing a role in LDL clearing, the researchers say the protein has other physiological functions, such as cancer tumor invasion. Knowing this, the team is collaborating with oncologists to investigate this angle of prospective drug development for cancer treatments. 

"The one protein is a shared risk factor for the two most common diseases in humans -- cancer and cardiovascular disease," Zhang concludes. "We will explore whether we can target one protein to reduce the incidence of the two most common human diseases."

Sources: Nature Communications, Science Daily

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 25, 2022
Cancer
Does the Secret to Immunotherapy Lie in...Poop?
JUL 25, 2022
Does the Secret to Immunotherapy Lie in...Poop?
Advancements in immunotherapy have proven instrumental in reshaping the face of cancer research in recent years.  W ...
AUG 18, 2022
Clinical & Molecular DX
New Research Investigates the Molecular Spread of Triple-Negative Breast Cancer
AUG 18, 2022
New Research Investigates the Molecular Spread of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancer cases. TNBC is a term used to describe cas ...
AUG 22, 2022
Immunology
A Lifetime of Mutations is Seen in Aging Immune Cells
AUG 22, 2022
A Lifetime of Mutations is Seen in Aging Immune Cells
Researchers have used advanced sequencing techniques to analyze immune cells in great detail. This work has shown that o ...
SEP 13, 2022
Health & Medicine
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
SEP 13, 2022
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
A 2022 Centers for Diseases Control and Prevention (CDC) report showed only 2,385 mesothelioma cases in the United State ...
SEP 15, 2022
Cancer
Early-Onset Cancers are Rising: Do We Know Why?
SEP 15, 2022
Early-Onset Cancers are Rising: Do We Know Why?
Early-onset cancers, typically defined as those diagnosed in people aged approximately 20 - 50, have continually increas ...
NOV 22, 2022
Clinical & Molecular DX
Women With Benign Breast Diseases, Including Cysts and Fibroadenomas, Face Higher Risk of Breast Cancer
NOV 22, 2022
Women With Benign Breast Diseases, Including Cysts and Fibroadenomas, Face Higher Risk of Breast Cancer
Though they are very common, benign breast diseases may indicate an increased likelihood of developing breast cancer at ...
Loading Comments...